July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Risk and Prognostic Factors of Neovascular Glaucoma After 25-gage Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study
Author Affiliations & Notes
  • Kei Takayama
    National Defense Medical College, Tokorozawa, Japan
  • Hideaki Someya
    National Defense Medical College, Tokorozawa, Japan
  • Hiroshi Yokoyama
    Hyogo College of Medicine, Japan
  • Yoshihiro Takamura
    University of Fukui Faculty of Medical Sciences, Japan
  • Masakazu Morioka
    University of Fukui Faculty of Medical Sciences, Japan
  • Seiji Sameshima
    Kagoshima University, Japan
  • Tetsuo Ueda
    Nara Medical University, Japan
  • Shigehiko Kitano
    Tokyo Women’s Medical University School of Medicine, Japan
  • Maki Tashiro
    Tokyo Women’s Medical University School of Medicine, Japan
  • Masahiko Sugimoto
    Mie University, Japan
  • Mineo Kondo
    Mie University, Japan
  • Taiji Sakamoto
    Kagoshima University, Japan
  • Masaru Takeuchi
    National Defense Medical College, Tokorozawa, Japan
  • Footnotes
    Commercial Relationships   Kei Takayama, None; Hideaki Someya, None; Hiroshi Yokoyama, None; Yoshihiro Takamura, None; Masakazu Morioka, None; Seiji Sameshima, None; Tetsuo Ueda, None; Shigehiko Kitano, None; Maki Tashiro, None; Masahiko Sugimoto, None; Mineo Kondo, None; Taiji Sakamoto, None; Masaru Takeuchi, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 6562. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kei Takayama, Hideaki Someya, Hiroshi Yokoyama, Yoshihiro Takamura, Masakazu Morioka, Seiji Sameshima, Tetsuo Ueda, Shigehiko Kitano, Maki Tashiro, Masahiko Sugimoto, Mineo Kondo, Taiji Sakamoto, Masaru Takeuchi; Risk and Prognostic Factors of Neovascular Glaucoma After 25-gage Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study. Invest. Ophthalmol. Vis. Sci. 2019;60(9):6562.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To identify risk and prognostic factors of postoperative neovascular glaucoma (NVG) in eyes which underwent 25-gage vitrectomy for proliferative diabetic retinopathy (PDR) with vitreous hemorrhage (VH).

Methods : Medical records of 272 eyes of 272 consecutive PDR patients with VH (mean age 56.6 ± 12.7 years) that underwent 25-gage vitrectomy between March 2010 and December 2016 at seven centers were retrospectively reviewed. Preoperative ocular factors (visual acuity, tractional retinal detachment, panretinal photocoagulation [PRP]), general factors (sex, age, diabetic duration, HbA1c, hypertension, anti-coagulant medication, and kidney function), and surgical procedures (preoperative intravitreal anti-vascular endothelial growth factor injection, internal limiting membrane peeling, cataract surgery, iatrogenic retinal tear, and tamponade procedure), and postoperative complications during 12-month follow up were extracted, and were compared between postoperative NVG patients (NVG group; 25 eyes, 9.2%) and non-NVG patients (non-NVG group; 247 eyes).

Results : NVG group was significantly younger age (50.8 ± 12.3 vs 56.9 ± 13.1; P = 0.012), shorter diabetic duration (9.2 ± 5.9 years vs 13.6 ± 10.1 years; P = 0.039), higher HbA1c level (8.4 ± 2.8 % vs 7.5 ± 1.7%; P = 0.032), and more postoperative VH (48% vs 22.8%; P = 0.0047) than non-NVG group. Logistic regression analysis showed that postoperative VH (P = 0.016), shorter diabetic duration (P = 0.030), and absence of PRP (P = 0.030) were prognostic factors for postoperative NVG.

Conclusions : These results indicate that younger age, uncontrolled diabetes, lack of PRP, and postoperative VH are risk and/or prognostic factors of postoperative NVG.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×